< Back

ABSTRACT

High-grade primary tumors of the central nervous system: Clinical and epidemiological analysis of the experience of a center

doi: 10.24875/j.gamo.M22000226

Full Article in PDF (English)

Tumores primarios de alto grado del sistema nervioso central: análisis clínico y epidemiológico de la experiencia de un centro

doi: 10.24875/j.gamo.22000208

Full Article in PDF (Spanish)


VOLUME 21 - NUMBER 2 / April - June (Original article / Artículo original)


Patricio G. García-Espinosa, Facultad de Medicina, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, N.L. México
Edgar Botello-Hernández, Facultad de Medicina, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, N.L. México
Leopoldo Pérez-García, Facultad de Medicina, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, N.L. México
Patricio Guerra-Maldonado, Facultad de Medicina, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, N.L. México
José H. Fabela-Rodríguez, Facultad de Medicina, Departamento de Medicina Preventiva y Salud Pública. Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, N.L. México



Background: Epidemiological data on the clinical presentation of high-grade primary tumors, the most common histological variables and prevalence, and sociodemographic variables were addressed from January 2016 to December 2020. Method: The sample was calculated from the primary tumors provided by the statistics department, determined the ICD-10 (C-71), finding 105. Results: 114 cases of high-grade primary tumors, most of them men; glioblastoma was the most common variant, followed by medulloblastoma. The frontal lobe was the most common location, consultation times lasted between 3-6 months, the most common clinical symptom was headache; the most common reason for consultation were seizures. Conclusion: The paradigm shift in the treatment of primary brain tumors from a molecular profile, and not precisely histological, will be the next step to take. These tumors are of great epidemiological importance and an opportunity to carry out preventive medicine and health promotion campaigns.


Keywords: Brain neoplasms. Central nervous system. Pediatrics. Oncology.